MYC and non-small cell lung carcinoma: Furthermore, while rapamycin treatment significantly decreased c-Myc levels in H460 cells, the difference in c-Myc expression in H292 cells was not statistically significant, suggesting potential variability in the response to mTOR inhibition among NSCLC cell lines.